Literature DB >> 14733856

[Treatment of latent tuberculosis among homeless population. Comparison between wo therapeutic approaches].

Ignacio Sánchez-Arcilla1, José María Vílchez, Manuel García de la Torre, Xiomara Fernández, Arturo Noguerado.   

Abstract

BACKGROUND AND
OBJECTIVE: We aimed to compare treatment adherence and toxicity of isoniazide (H) (6 months) compared with rifampicine (R) + pirazinamide (Z) (2 months) in homeless patients in latent tuberculous infection (LTBI). PATIENTS AND
METHOD: Randomized and controlled prospective study.
RESULTS: We included 172 patients (116 males and 56 females) with an age average of 42.3 (12.8) years; 31 (18%) had recent conversion and 72 (41.8%) had some risk factor of hepatotoxicity. Both bivariate and multivariate analysis (p < 0.001; OR = 5.15 [2.34-11.35]) showed that the treatment was completed by 61.5% of patients administered the R+Z regimen, while it was completed only by 28.2% of those administered H for 6 months. Moreover, treatment was completed by 48.4% of Spanish or foreign patients with legal residence, while it was completed only by 28.6% of immigrant patients with no legal residence (p = 0.044 in bivariate analysis).
CONCLUSIONS: The R+Z regimen for 2 months as treatment of LTBI in homeless patients displays a higher adherence than H for 6 months. There were no differences in toxicity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14733856     DOI: 10.1016/s0025-7753(04)74140-8

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  3 in total

1.  Tuberculosis control in vulnerable groups.

Authors:  Jose I Figueroa-Munoz; Pilar Ramon-Pardo
Journal:  Bull World Health Organ       Date:  2008-09       Impact factor: 9.408

Review 2.  Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: a systematic review with network meta-analyses.

Authors:  Christopher Pease; Brian Hutton; Fatemeh Yazdi; Dianna Wolfe; Candyce Hamel; Pauline Quach; Becky Skidmore; David Moher; Gonzalo G Alvarez
Journal:  BMC Infect Dis       Date:  2017-04-11       Impact factor: 3.090

3.  Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020.

Authors:  Timothy R Sterling; Gibril Njie; Dominik Zenner; David L Cohn; Randall Reves; Amina Ahmed; Dick Menzies; C Robert Horsburgh; Charles M Crane; Marcos Burgos; Philip LoBue; Carla A Winston; Robert Belknap
Journal:  MMWR Recomm Rep       Date:  2020-02-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.